Not all products have to meet the U.S. Federal Drug Administration’s (FDA) approval: certain biologics and dietary supplements do not require it, and there are alternative pathways for OTC drugs and other products to skip the process.read more
The US Food and Drug Administration (FDA) has announced new restrictions concerning the marketing of tobacco products such as e-cigarettes and vape pens in an effort to mitigate risks to public health.read more
Opioid drugmakers Insys Therapeutics and Mallinckrodt Pharmaceuticals face millions of dollars in settlement as a consequence of allegedly bribing doctors to prescribe their drugs.read more
The opinions stated in this blog are the sole and present opinions of the blogger and do not necessarily represent the opinions of the Kulkarni Law Firm, PC and/or its attorneys. Such opinion(s) may change over time. Such opinion(s) should not necessarily be attributed to the institution for which these individuals may work or otherwise represent in any capacity. These blogs do not constitute legal advice and should not be construed as such.